Here are the 8-K filings from OneMedNet Corp Warrant (ONMDW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow ONMDW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONMDW filings page.
OneMedNet Corp. (ONMD) regained compliance with Nasdaq’s $1.00 minimum bid price requirement after Nasdaq staff confirmed the common stock’s closing bid price was at least $1.00 per share for 10 consecutive business days, from September 29, 2026 through October 12, 2026. Nasdaq’s notice, received October 13, 2026, states that the matter is closed.
The company had received a notice of noncompliance on April 14, 2026, with a grace period until October 12, 2026 to regain compliance.
OneMedNet Corp. (ONMD) will implement a 1-for-10 reverse stock split effective at 12:01 a.m. Eastern Time on September 29, 2026; each 10 issued and outstanding common shares will become one share. The company says the split is intended to bring it into compliance with the Nasdaq Capital Market’s minimum bid price requirement.
The corporate-action description estimates outstanding shares will change from approximately 60,125,902 as of September 27, 2026, to approximately 6,012,591 after the split. The accompanying announcement separately gives approximately 59,286,450 shares as of September 24, 2026, and approximately 5,928,645 after the split. Fractional shares will be rounded up; authorized shares, par value and voting rights will not change.
OneMedNet Corporation (ONMD) stockholders approved an amendment to the Amended and Restated 2022 Equity Incentive Plan, increasing its authorized share count by 1,000,000 shares; the amendment became effective immediately upon approval. Stockholders also approved a charter amendment to effect a reverse stock split at a whole-number ratio from 1-for-5 to 1-for-20, with the ratio determined by the Board of Directors in its discretion.
At the September 18, 2026 annual meeting, stockholders elected Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu as Class III directors for terms ending at the 2029 annual meeting, and ratified WithumSmith+Brown, PC as the independent registered public accounting firm for the year ending December 31, 2026. A total of 41,841,452 votes were represented in person or by proxy, equal to 70.57% of votes entitled to be cast and constituting a quorum.
OneMedNet Corporation has set September 18, 2026 as the date of its 2026 Annual Meeting of Stockholders, with August 11, 2026 as the record date for stockholders entitled to notice of and to vote at the meeting.
Stockholder proposals for inclusion in the company’s proxy materials, other stockholder proposals, and nominations of director candidates must all be received by the Secretary of the company no later than August 5, 2026, in accordance with SEC Rule 14a-8, SEC Rule 14a-19 for any director election contest, and the company’s Bylaws.
OneMedNet Corporation entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. that allows the company, at its option, to sell up to $25 million of common stock over time. Sales can begin only after a resale registration statement for these shares becomes effective.
The agreement runs for 36 months. Each advance is limited to the greater of 500,000 shares and 100% of the stock’s five-day average trading volume, and is priced at 97% of the Market Price as defined in the agreement. Yorkville cannot exceed 4.99% beneficial ownership and, absent shareholder approval, total issuances are capped at 11,386,834 shares, which the company states is 19.99% of the 56,952,652 shares outstanding as of June 30, 2026.
OneMedNet Corporation reported that Nasdaq has notified the company its common stock no longer meets the $1.00 minimum bid price requirement, after trading below that level for 30 consecutive business days. The company has 180 days, until October 12, 2026, to regain compliance by having its share price at or above $1.00 for at least ten consecutive business days. If it still does not comply, OneMedNet may qualify for an additional 180-day period if it meets other Nasdaq Capital Market listing standards and commits to a plan that may include a reverse stock split. The company notes there is no assurance it will regain or maintain compliance, and failure to do so could result in Nasdaq delisting its shares.